These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Treatment of Parkinson's disease--where do we go from here? Suchowersky O Nat Clin Pract Neurol; 2006 Sep; 2(9):461. PubMed ID: 16932605 [No Abstract] [Full Text] [Related]
29. Impulsive and compulsive behaviors in Parkinson's disease. Evans AH; Strafella AP; Weintraub D; Stacy M Mov Disord; 2009 Aug; 24(11):1561-70. PubMed ID: 19526584 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study. Ziegler M; Castro-Caldas A; Del Signore S; Rascol O Mov Disord; 2003 Apr; 18(4):418-25. PubMed ID: 12671949 [TBL] [Abstract][Full Text] [Related]
31. Pathological gambling in Parkinson's disease--a review of the literature. Djamshidian A; Cardoso F; Grosset D; Bowden-Jones H; Lees AJ Mov Disord; 2011 Sep; 26(11):1976-84. PubMed ID: 21661054 [TBL] [Abstract][Full Text] [Related]
33. Selective IGT decision-making impairment in a patient with juvenile Parkinson's disease and pathological gambling: a role for dopaminergic therapy? Pignatti R; Brioschi A; Mauro A; Zamarian L; Wenter J; Semenza C Neurocase; 2012; 18(6):503-13. PubMed ID: 22224448 [TBL] [Abstract][Full Text] [Related]
34. The Efficacy and Safety of Piribedil Relative to Pramipexole for the Treatment of Early Parkinson Disease: A Systematic Literature Review and Network Meta-Analysis. Chen X; Ren C; Li J; Wang S; Dron L; Harari O; Whittington C Clin Neuropharmacol; 2020; 43(4):100-106. PubMed ID: 32658035 [TBL] [Abstract][Full Text] [Related]
36. [Pathological gambling induced by dopamine agonists]. Gahr M; Connemann BJ; Schönfeldt-Lecuona CJ Fortschr Neurol Psychiatr; 2011 Aug; 79(8):470-4. PubMed ID: 21809260 [TBL] [Abstract][Full Text] [Related]
37. Problematic gambling on dopamine agonists: Not such a rarity. Grosset KA; Macphee G; Pal G; Stewart D; Watt A; Davie J; Grosset DG Mov Disord; 2006 Dec; 21(12):2206-8. PubMed ID: 17013907 [TBL] [Abstract][Full Text] [Related]
38. Impulse control disorders in Parkinson's disease: a psychosocial perspective. Delaney M; Leroi I; Simpson J; Overton PG J Clin Psychol Med Settings; 2012 Sep; 19(3):338-46. PubMed ID: 22581074 [TBL] [Abstract][Full Text] [Related]
39. Factors associated with the development of impulse compulsive disorders in Parkinson patients. Rana AQ; Mansoor W; Hussaini S; Al Mosabbir A; Rahman M; Rahman L Int J Neurosci; 2013 Jul; 123(7):503-6. PubMed ID: 23336737 [TBL] [Abstract][Full Text] [Related]
40. Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Ray NJ; Miyasaki JM; Zurowski M; Ko JH; Cho SS; Pellecchia G; Antonelli F; Houle S; Lang AE; Strafella AP Neurobiol Dis; 2012 Dec; 48(3):519-25. PubMed ID: 22766031 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]